Revolution Medicines Inc
RVMD · NASDAQ
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers. The company possesses sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites.
Market Data
Price
$98.86
-0.93 (-0.93%)
Market Cap$19.78B
P/E Ratio—
EPS$—
52W High$124.49
52W Low$29.17
Beta1.15
Data from Finnhub · Updated Mar 11, 2026